Erlotinib Hydrochloride and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery

This study is currently recruiting participants.

Verified January 2013 by Comprehensive Cancer Center of Wake Forest University

Sponsor:

Collaborator:

Information provided by (Responsible Party):

Comprehensive Cancer Center of Wake Forest University

ClinicalTrials.gov Identifier:

NCT01588613

First received: April 17, 2012

Last updated: January 25, 2013

Last verified: January 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	July 2014 (Final data collection date for primary outcome measure)